165 related articles for article (PubMed ID: 35242698)
41. Exploring the sonodynamic effects of bacteriochlorophyll a.
Jia L; Wang L; Song Y; Pang X; Zhao J
Front Bioeng Biotechnol; 2023; 11():1186897. PubMed ID: 37251570
[No Abstract] [Full Text] [Related]
42. Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance.
Kim S; Im JH; Kim WK; Choi YJ; Lee JY; Kim SK; Kim SJ; Kwon SW; Kang KW
Oxid Med Cell Longev; 2021; 2021():5428364. PubMed ID: 34367462
[TBL] [Abstract][Full Text] [Related]
43. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
44. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer.
Ready N
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S35-41. PubMed ID: 16015534
[TBL] [Abstract][Full Text] [Related]
46. IR780-based diffuse fluorescence tomography for cancer detection.
He Z; Zhang L; Xing L; Sun W; Gao X; Zhang Y; Gao F
J Biophotonics; 2024 May; 17(5):e202300493. PubMed ID: 38329194
[TBL] [Abstract][Full Text] [Related]
47. ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells.
Kol A; Terwisscha van Scheltinga A; Pool M; Gerdes C; de Vries E; de Jong S
Oncotarget; 2017 Jul; 8(28):45432-45446. PubMed ID: 28467975
[TBL] [Abstract][Full Text] [Related]
48. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
[TBL] [Abstract][Full Text] [Related]
49. Theranostic Nanoplatform with Sequential SDT and ADV Effects in Response to Well-Programmed LIFU Irradiation for Cervical Cancer.
Zhou J; Hou J; Liu S; Xu J; Luo Y; Zheng J; Li X; Wang Z; Ran H; Guo D
Int J Nanomedicine; 2021; 16():7995-8012. PubMed ID: 34916791
[TBL] [Abstract][Full Text] [Related]
50. IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer.
Song J; Zhang N; Zhang L; Yi H; Liu Y; Li Y; Li X; Wu M; Hao L; Yang Z; Wang Z
Int J Nanomedicine; 2019; 14():2757-2772. PubMed ID: 31118609
[No Abstract] [Full Text] [Related]
51. Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.
Li S; Johnson J; Peck A; Xie Q
J Transl Med; 2017 Jan; 15(1):18. PubMed ID: 28114956
[TBL] [Abstract][Full Text] [Related]
52. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
53. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
[TBL] [Abstract][Full Text] [Related]
54. Anti-EGFR Peptide-Conjugated Triangular Gold Nanoplates for Computed Tomography/Photoacoustic Imaging-Guided Photothermal Therapy of Non-Small Cell Lung Cancer.
Zhao Y; Liu W; Tian Y; Yang Z; Wang X; Zhang Y; Tang Y; Zhao S; Wang C; Liu Y; Sun J; Teng Z; Wang S; Lu G
ACS Appl Mater Interfaces; 2018 May; 10(20):16992-17003. PubMed ID: 29722264
[TBL] [Abstract][Full Text] [Related]
55. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
56. Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
Biochem Biophys Res Commun; 2013 Feb; 431(3):623-9. PubMed ID: 23266614
[TBL] [Abstract][Full Text] [Related]
57. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
[TBL] [Abstract][Full Text] [Related]
58. Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling.
Wang W; Xia X; Chen K; Chen M; Meng Y; Lv D; Yang H
Front Oncol; 2021; 11():665045. PubMed ID: 34168988
[TBL] [Abstract][Full Text] [Related]
59. Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer.
Wu Y; Li H; Yan Y; Wang K; Cheng Y; Li Y; Zhu X; Xie J; Sun X
Int J Nanomedicine; 2020; 15():4691-4703. PubMed ID: 32636625
[TBL] [Abstract][Full Text] [Related]
60. Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.
Furugaki K; Fukumura J; Iwai T; Yorozu K; Kurasawa M; Yanagisawa M; Moriya Y; Yamamoto K; Suda K; Mizuuchi H; Mitsudomi T; Harada N
Int J Cancer; 2016 Feb; 138(4):1024-32. PubMed ID: 26370161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]